FAQ: Nutriband Inc. (NASDAQ: NTRB) Participation in the Emerging Growth Conference

Summary
What is Nutriband Inc. presenting at the Emerging Growth Conference?
Nutriband Inc. will present its AVERSA(TM) abuse-deterrent technology, focusing on its application in transdermal pharmaceutical products, including an abuse-deterrent fentanyl patch.
When is the Emerging Growth Conference where Nutriband Inc. will present?
The conference is scheduled for August 20, 2025.
Who will represent Nutriband Inc. at the Emerging Growth Conference?
Chairman Serguei Melnik will deliver the presentation and may engage in a live Q&A session with attendees.
What is AVERSA(TM) technology?
AVERSA(TM) is Nutriband’s proprietary technology designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential in transdermal patches.
How can I view Nutriband Inc.’s presentation at the Emerging Growth Conference?
Details on viewing the presentation can be found in the full article at https://ibn.fm/dhj3J.
Where can I find the latest news and updates about Nutriband Inc.?
The latest updates are available in the company’s newsroom at https://ibn.fm/NTRB.
What is the significance of Nutriband’s participation in the Emerging Growth Conference?
This presentation highlights Nutriband’s innovative approach to preventing drug abuse through its AVERSA(TM) technology, potentially attracting investors and partners interested in pharmaceutical safety.
Can I receive SMS alerts from BioMedWire about Nutriband Inc. and similar companies?
Yes, by texting ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only), you can receive SMS alerts from BioMedWire.
What is BioMedWire?
BioMedWire is a specialized communications platform focusing on Biotechnology, Biomedical Sciences, and Life Sciences, providing news distribution and corporate communications solutions.
How does BioMedWire enhance press release distribution?
BioMedWire offers enhanced press release services, social media distribution, and access to a vast network of wire solutions to maximize impact and reach diverse audiences.

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 164037